These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 12134253

  • 1. Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of pediatric AIDS clinical trials group protocol 316.
    Cunningham CK, Chaix ML, Rekacewicz C, Britto P, Rouzioux C, Gelber RD, Dorenbaum A, Delfraissy JF, Bazin B, Mofenson L, Sullivan JL.
    J Infect Dis; 2002 Jul 15; 186(2):181-8. PubMed ID: 12134253
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Resistance mutations in HIV-1 infected pregnant women and their infants receiving antiretrovirals to prevent HIV-1 vertical transmission in China.
    Han J, Wang L, Jiang Y, Zhang Q, Fang L, Yao J, Wang Q.
    Int J STD AIDS; 2009 Apr 15; 20(4):249-54. PubMed ID: 19304969
    [Abstract] [Full Text] [Related]

  • 4. Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.
    Chalermchockcharoenkit A, Culnane M, Chotpitayasunondh T, Vanprapa N, Leelawiwat W, Mock PA, Asavapiriyanont S, Teeraratkul A, McConnell MS, McNicholl JM, Tappero JW.
    Clin Infect Dis; 2009 Jul 15; 49(2):299-305. PubMed ID: 19522656
    [Abstract] [Full Text] [Related]

  • 5. Drug resistance among HIV-infected pregnant women receiving antiretrovirals for prophylaxis.
    Duran AS, Losso MH, Salomón H, Harris DR, Pampuro S, Soto-Ramirez LE, Duarte G, de Souza RS, Read JS, NISDI Perinatal Study Group.
    AIDS; 2007 Jan 11; 21(2):199-205. PubMed ID: 17197811
    [Abstract] [Full Text] [Related]

  • 6. Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1.
    TEmAA ANRS 12109 Study group, Arrivé E, Chaix ML, Nerrienet E, Blanche S, Rouzioux C, Coffie PA, Kruy Leang S, McIntyre J, Avit D, Srey VH, Gray G, N'Dri-Yoman T, Diallo A, Ekouévi DK, Dabis F.
    AIDS; 2009 Apr 27; 23(7):825-33. PubMed ID: 19307941
    [Abstract] [Full Text] [Related]

  • 7. Protease inhibitor-based antiretroviral prophylaxis during pregnancy and the development of drug resistance.
    Gingelmaier A, Eberle J, Kost BP, Bogner JR, Hofmann J, Weissenbacher T, Kästner R, Friese K, Weizsaecker K.
    Clin Infect Dis; 2010 Mar 15; 50(6):890-4. PubMed ID: 20166821
    [Abstract] [Full Text] [Related]

  • 8. Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated.
    Johnson JA, Li JF, Morris L, Martinson N, Gray G, McIntyre J, Heneine W.
    J Infect Dis; 2005 Jul 01; 192(1):16-23. PubMed ID: 15942889
    [Abstract] [Full Text] [Related]

  • 9. HIV-1 drug resistance and mother-to-child transmission.
    Morris L, Pillay C, Gray G, McIntyre J.
    SADJ; 2001 Dec 01; 56(12):614-6. PubMed ID: 11887450
    [Abstract] [Full Text] [Related]

  • 10. Nevirapine resistance after single dose prophylaxis.
    Eshleman SH, Jackson JB.
    AIDS Rev; 2002 Dec 01; 4(2):59-63. PubMed ID: 12152519
    [Abstract] [Full Text] [Related]

  • 11. New mutations associated with resistance not detected following zidovudine monotherapy in pregnancy when used in accordance with British HIV Association guidelines.
    Read P, Costelloe S, Mullen J, O'Shea S, Lyons F, Hay P, Welch J, Larbalestier N, Taylor G, de Ruiter A.
    HIV Med; 2008 Aug 01; 9(7):448-51. PubMed ID: 18840150
    [Abstract] [Full Text] [Related]

  • 12. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
    Moodley D, Moodley J, Coovadia H, Gray G, McIntyre J, Hofmyer J, Nikodem C, Hall D, Gigliotti M, Robinson P, Boshoff L, Sullivan JL, South African Intrapartum Nevirapine Trial (SAINT) Investigators.
    J Infect Dis; 2003 Mar 01; 187(5):725-35. PubMed ID: 12599045
    [Abstract] [Full Text] [Related]

  • 13. Antiretroviral resistance mutations among pregnant human immunodeficiency virus type 1-infected women and their newborns in the United States: vertical transmission and clades.
    Palumbo P, Holland B, Dobbs T, Pau CP, Luo CC, Abrams EJ, Nesheim S, Vink P, Respess R, Bulterys M, Perinatal AIDS Collaborative Transmission Studfy.
    J Infect Dis; 2001 Nov 01; 184(9):1120-6. PubMed ID: 11598834
    [Abstract] [Full Text] [Related]

  • 14. Effective program against mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso.
    Simpore J, Pietra V, Pignatelli S, Karou D, Nadembega WM, Ilboudo D, Ceccherini-Silberstein F, Ghilat-Avoid-Belem WN, Bellocchi MC, Saleri N, Sanou MJ, Ouedraogo CM, Nikiema JB, Colizzi V, Perno CP, Castelli F, Musumeci S.
    J Med Virol; 2007 Jul 01; 79(7):873-9. PubMed ID: 17516517
    [Abstract] [Full Text] [Related]

  • 15. Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana.
    Shapiro RL, Thior I, Gilbert PB, Lockman S, Wester C, Smeaton LM, Stevens L, Heymann SJ, Ndung'u T, Gaseitsiwe S, Novitsky V, Makhema J, Lagakos S, Essex M.
    AIDS; 2006 Jun 12; 20(9):1281-8. PubMed ID: 16816557
    [Abstract] [Full Text] [Related]

  • 16. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK, Coffie PA, Becquet R, Tonwe-Gold B, Horo A, Thiebaut R, Leroy V, Blanche S, Dabis F, Abrams EJ.
    AIDS; 2008 Sep 12; 22(14):1815-20. PubMed ID: 18753864
    [Abstract] [Full Text] [Related]

  • 17. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.
    Dao H, Mofenson LM, Ekpini R, Gilks CF, Barnhart M, Bolu O, Shaffer N.
    Am J Obstet Gynecol; 2007 Sep 12; 197(3 Suppl):S42-55. PubMed ID: 17825650
    [Abstract] [Full Text] [Related]

  • 18. Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study).
    Eshleman SH, Becker-Pergola G, Deseyve M, Guay LA, Mracna M, Fleming T, Cunningham S, Musoke P, Mmiro F, Jackson JB.
    J Infect Dis; 2001 Oct 01; 184(7):914-7. PubMed ID: 11509999
    [Abstract] [Full Text] [Related]

  • 19. Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States.
    Persaud D, Palumbo P, Ziemniak C, Chen J, Ray SC, Hughes M, Havens P, Purswani M, Gaur AH, Chadwick EG, Pediatric AIDS Clinical Trials Group P1030 Team.
    J Infect Dis; 2007 May 15; 195(10):1402-10. PubMed ID: 17436219
    [Abstract] [Full Text] [Related]

  • 20. Low rate of emergence of nevirapine and lamivudine resistance after post-partum interruption of a triple-drug regimen.
    Pérez H, Vignoles M, Laufer N, Gómez A, Coll P, Lottner J, Rolón M, Salomón H, Cahn P.
    Antivir Ther; 2008 May 15; 13(1):135-9. PubMed ID: 18389908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.